Another common reason that people may choose to stop taking a GLP-1 RA is because of side effects such as nausea and vomiting
If youre new to building a routine, our Health Quiz can help point you toward the right starting place
Canadian generics now reaching pharmacies Health Canada authorized the first generic semaglutide injection on April 28, 2026, calling it the first such authorization in the G7 [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]
Tirzepatide Tirzepatide (Mounjaro), an FDA-approved injectable medication for type 2 diabetes, is under accelerated review for treating obesity
Inflamed L-cells struggle to produce GLP-1, which is why an A2-only alternative is recommended
We are dedicated to providing compassionate care that respects every individuals unique journey, combining advanced medical science with modern technology